VOICE AND SPEECH IN PARKINSON'S DISEASE: CLINICAL CHARACTERISTICS OF HYPOKINETIC DYSPHONIA

  • Ivana Ilic Savic University of Belgrade - Faculty of Special Education and Rehabilitation, Belgrade, Serbia
  • Mirjana Petrović-Lazić University of Belgrade - Faculty of Special Education and Rehabilitation, Belgrade, Serbia
  • Snežana Babac University of Belgrade - Faculty of Special Education and Rehabilitation, Belgrade, Serbia; Clinical Hospital Center “Zvezdara”, Belgrade, Serbia
Keywords: Parkinson's disease, hypokinetic dysphonia, voice and speech disorders, paralinguistic communication

Abstract


Parkinson's disease is a chronic, progressive neurodegenerative disease that is primarily manifested by motor disorders, but significantly affects voice and speech. One of the frequent and clinically significant manifestations of the disease is hypokinetic dysphonia, which occurs as a result of central dopaminergic deficit and hypokinesia of muscles involved in respiration, phonation and articulation. The aim of this review is to present the basic neurological and clinical characteristics of Parkinson's disease, the mechanisms of hypokinetic dysphonia, as well as the voice, speech and paralinguistic characteristics of patients with this disease, while considering the implications for clinical and speech therapy practice. The search for relevant sources was carried out using Google Scholar Advanced Search and the Consortium of Libraries of Serbia for Unified Procurement (KoBSON), where modern sources from the fields of neurology, phoniatrics and speech therapy were analyzed. The results of the review indicate that voice and speech disorders, including hypophonia, monotony, reduced intonation variation and disorganized prosody, significantly impair communication and the quality of life of sufferers. Paralinguistic communication deficits, which contribute to the social isolation of patients, are especially pronounced. It is concluded that timely recognition of hypokinetic dysphonia and an interdisciplinary approach, along with active involvement in speech therapy treatment, is of key importance for preserving communication skills and improving the overall functioning of people with Parkinson's disease.

 

References

Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson’s disease. Mov Disord. 2017;32(9):1264–1310. doi:10.1002/mds.27115

Jankovic J. Parkinson’s disease: Clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376. doi:10.1136/jnnp.2007.131045

Duffy JR. Motor speech disorders: substrates, differential diagnosis, and management. 4th ed. Amsterdam: Elsevier; 2019.

Ramig LO, Fox C, Sapir S. Speech treatment for Parkinson’s disease. Expert Rev Neurother. 2008;8(2):297–309. doi:10.1586/14737175.8.2.297

Kent RD, Kim Y. Toward an acoustic typology of motor speech disorders. Clin Linguist Phon. 2003;17(6):427–445. doi:10.1080/0269920031000138118

Skodda S, Visser W, Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm. 2011;118(2):197–205. doi:10.1007/s00702-010-0528-6

Miller N, Noble E, Jones D, Burn D. Life with communication changes in Parkinson’s disease. Age Ageing. 2011;40(2):235–239. doi:10.1093/ageing/afq167

Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, et al. Parkinson disease–associated cognitive impairment. Nat Rev Dis Primers. 2017;3:17085. doi:10.1038/nrdp.2017.85

Rusz J, Tykalová T, Ramig LO, Tripoliti E, Skodda S. Guidelines for speech recording and acoustic analyses in Parkinson’s disease. J Voice. 2018;32(6):663–680. doi:10.1016/j.jvoice.2017.08.005

Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson disease: long-term effects. J Speech Lang Hear Res. 2020;63(7):2315–2332. doi:10.1044/2020_JSLHR-19-00249

Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the Lee Silverman Voice Treatment. Semin Speech Lang. 2018;39(2):123–133. doi:10.1055/s-0038-1636534

Published
2026/05/29
Section
Review article